Toronto Offseason Gets Off To Brutal Start

As the Blue Jays see roster changes with Joe Mantiply opting for free agency and bid farewell to retired star Liam Hendriks, three players shine with All-MLB nominations.

The Blue Jays’ offseason ledger is already getting busy, and Tuesday brought a little of everything: a veteran reliever hitting free agency, three Toronto standouts landing on the All-MLB ballot, and Liam Hendriks officially closing the book on a 14-year major-league career.

Joe Mantiply is back on the market after clearing waivers and electing free agency. The 35-year-old lefty spent one season with Toronto, finishing 2-0 with a 3.00 ERA, a 1.19 WHIP and 22 strikeouts across 27 innings. Opponents batted .265 against him in 25 appearances.

Mantiply arrived on a minor-league deal in March and made his Blue Jays debut in early April. He opened with a 3.09 ERA over 11.2 innings in April, then started May strong as well, holding hitters to a .200 average and not allowing a run in six innings.

But his season took a hit after his May 17 outing, when he needed arthroscopic surgery on his left knee and missed time until August. Once rosters expanded on Sept. 1, he wasn’t quite the same pitcher, posting a 4.82 ERA and 1.29 WHIP in eight September appearances before being sent down.

Toronto also had three players earn recognition for their work this season. Rookie third baseman Kazuma Okamoto, starter Dylan Cease and reliever Louis Varland were named finalists for the 2026 All-MLB Team.

Okamoto made an immediate impact in the middle of the lineup, setting a franchise rookie record with 33 home runs and adding 92 RBI with a .762 OPS. Cease delivered ace-level production, going 2.40 with 239 strikeouts over 169 innings. Varland gave the bullpen a steady anchor, piling up 35 saves with a 1.27 ERA and 11.9 strikeouts per nine innings.

The All-MLB Team honors the top players at every position across both leagues, with voters choosing first and second teams. Five starting pitchers and two relievers are selected for each.

Hendriks, meanwhile, announced his retirement and did it in classic fashion, saying his arm had “exactly zero fastballs left” and that throwing harder than a light breeze now required an extended recovery. He leaves the game as a three-time All-Star, a two-time American League Reliever of the Year and the 2023 AL Comeback Player of the Year.

Hendriks’ final chapter was as impressive as it was inspiring. After being diagnosed with non-Hodgkin lymphoma in January 2023, he completed chemotherapy in April and returned to the mound in May after announcing he was cancer-free. He later received the Jimmy V Award for Perseverance at the ESPYs.

He also said, "To the cities that adopted me, the fans that cheered for me, my family, and every umpire who definitely missed a strike call on the corner: After years of staring down hitters, I have decided to officially retire from Major League Baseball."

Toronto was one of the cities that had him, even if the stint was short. Hendriks pitched in 61 games over a year and a half with the Blue Jays, including three starts, and logged a 3.46 ERA, 79 strikeouts, a 1.103 WHIP and 118 ERA+ across 78 innings.

His path with the Blue Jays was a winding one. Toronto claimed him off waivers before the 2014 season, then traded him to Kansas City at the deadline with Erik Kratz for Danny Valencia.

Kansas City sent him back to Toronto after that season, and he spent all of 2015 with the club, even throwing five innings in the playoffs during the Blue Jays’ run to the ALCS. Toronto later dealt him to the Athletics for Jesse Chavez.

In Other News...

Blue Jays Offseason Starts With Recognition And One Notable Exit

The Blue Jays offseason opened with a mix of recognition and roster turnover, the kind of early-November mix that can make a winter feel both celebratory and unsettled. Three players with Toronto ties - Kazuma Okamoto, Dylan Cease and Louis Varland - were named finalists for the 2026 All-MLB Team, a reminder that the clubs recent work has placed it among the games more prominent talent pools.

There was movement on the personnel side as well, with Joe Mantiply electing free agency after clearing waivers following his season in Toronto. And for one familiar former Blue Jay, the news carried a more final note: Liam Hendriks announced his retirement after a 14-year major league career, closing the book on a run that made him one of the sports most respected relievers. [Read more 🡒]

Blue Jays Reunion With Kevin Gausman Hinges On One Huge Question

Kevin Gausmans time in Toronto ended abruptly at the 2026 trade deadline, when the Blue Jays sent him to the Chicago Cubs, but the door may not be fully closed on a return. He is headed into free agency after the 2026 season, and Torontos need is obvious enough: the club has a vacancy in its starting rotation and would have room for a pitcher it knows well.

The bigger issue is whether there will even be a market to navigate. Gausman has already said retirement is a possibility, and that one question hangs over any talk of a reunion in 2027. If he keeps pitching, the Blue Jays figure to at least have a seat at the table. If not, the conversation ends before it really begins. [Read more 🡒]

Blue Jays Cant Stop Chasing Pitching Depth After This Latest Reminder

The Blue Jays are still doing what so many clubs with October ambitions eventually have to do: keep stockpiling arms and hoping the next one sticks. Their latest move brought in Jameson Taillon from the Cubs after he was designated for assignment, a reminder of how thin the line can be between a useful rotation piece and a pitcher fighting to stay on the mound. Toronto has seen enough of Taillon to know the profile, too, because his time with the club was defined as much by injuries as by innings, with forearm tendinitis and elbow pain cutting into his ability to contribute.

Even with the rough statistical season behind him, Taillon still fits the kind of low-risk, short-term flier teams like the Blue Jays keep circling back to when they are trying to protect themselves against attrition. He is not expected to need surgery this offseason, which matters in a market where durability often matters as much as upside, and it leaves open the possibility that Toronto could look at him again as a depth option. The bigger question is whether the Blue Jays see enough there to bring him back, or whether they keep searching for the kind of pitching insurance every contender eventually needs. [Read more 🡒]